Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NBIS vs GSK✓SelectedUSD · GSKNBIS vs GSK performance historyLatest closeAs of-9.92%11/13
Stock and ETF performance explorer

NBIS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-44.1%
GSK return
+3.0%
Excess return
-47.1%
Maximum drawdown
-59.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-9.9%+0.5%-10.4%-9.3%
7D-10.5%+1.1%-11.7%-9.3%
30D-37.7%+6.3%-44.0%-32.0%
3M-54.6%+1.8%-56.4%-52.0%
6M-44.1%+1.7%-45.7%-41.6%
All-44.1%+3.0%-47.1%-41.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling